Your browser doesn't support javascript.
loading
Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.
Cheung, Tommy Tsang; Mai, Tu H; Chia, Yen Lin; Yap, Desmond Y H; Lee, Chi-Ho; Chen, Cecil Chi-Keung; Huang, Ying; Jin, Yuwen; Johnston, James; Werkström, Viktoria; Yao, Yuhui; Ge, Xiaoyun; Zheng, Wenying.
Afiliação
  • Cheung TT; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, People's Republic of China.
  • Mai TH; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, South San Francisco, CA, USA.
  • Chia YL; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, South San Francisco, CA, USA.
  • Yap DYH; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, People's Republic of China.
  • Lee CH; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, People's Republic of China.
  • Chen CC; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, South San Francisco, CA, USA.
  • Huang Y; Clinical Pharmacology, R&D China, AstraZeneca, Shanghai, People's Republic of China.
  • Jin Y; Clinical Pharmacology, R&D China, AstraZeneca, Shanghai, People's Republic of China.
  • Johnston J; Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Werkström V; Late-Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Yao Y; Respiratory & Immunology, R&D China, AstraZeneca, Shanghai, People's Republic of China.
  • Ge X; Clinical Safety, R&D China, AstraZeneca, Shanghai, People's Republic of China.
  • Zheng W; Biometrics, R&D China, AstraZeneca, Shanghai, People's Republic of China.
Drug Des Devel Ther ; 17: 209-218, 2023.
Article em En | MEDLINE | ID: mdl-36726737
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article